(2-(4-methyl-2-phenylpiperazin-1-yl)pyridin-3-yl)methanol;1-(3-Hydroxymethyl-2-pyridyl)-4-methyl-2-phenylpiperazine; 1-[3-(Hydroxymethyl)pyridin-2-yl)-4-methyl-2-phenylpiperazine; 2-(4-Methyl-2-phenylpiperazin-1-yl)pyridine-3-methanol; Mirtazapine Impurity B;2-(4-Methyl-2-phenyl-1-piperazinyl)-3-pyridinemethanol
Mirtazapine EP Impurity B is a fully characterized chemical compound used as a reference standard of API Mirtazapine. The standard offered is compliant with regulatory guidelines. Mirtazapine EP Impurity B is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 61337-89-1
Related products
Mirtazapine-13C-d3 HCl
M.F. ₁₃C C₁₆H₁₆N₃D₃. HCl
M.W. 269.37 36.46
CAT# AR-M02040
CAS# 85650-52-8 (non-labelled and free base)
